The Cutting Copays Act would change Medicare Part D cost-sharing limits for people with low incomes. Before 2026, the limits would be no more than $1 for generic or certain preferred drugs and $3 for other drugs, or less if the amount otherwise applicable to the individual is lower. In 2026, the limit would be $0 for generic drugs. For other drugs, it would use the applicable 2023 amount. In later years, the limits would rise each year based on the consumer price index.
If you qualify for the low-income cost-sharing reductions in Medicare Part D, the proposal would set the copayment limits described above. The text does not explain who qualifies for those reductions.
The proposal specifies copayment limits but gives no estimate of federal spending or total costs.
No publicly available information.
No publicly available information.